Abstract:Purpose: Preoperative (neoadjuvant) radiation therapy (RT) is an essential part of multimodal rectal cancer therapy. Recently, total neoadjuvant therapy (TNT), which combines simultaneous radiochemotherapy with additional courses of chemotherapy, has emerged as an effective approach. TNT achieves a pathologic complete remission in approximately 30% of resected patients, opening avenues for treatment strategies that avoid radical organ resection. Furthermore, recent studies have demonstrated that anti-programmed cell death protein 1 immunotherapy can induce clinical complete responses in patients with specific genetic alterations. There is significant potential to enhance outcomes through intensifying, personalizing, and de-escalating treatment approaches. However, the heterogeneous response rates to RT or TNT and strategies to sensitize patients without specific genetic changes to immunotherapy remain poorly understood. Methods and materials: We developed a novel orthotopic mouse model of rectal cancer based on precisely defined endoscopic injections of tumor organoids that reflect tumor heterogeneity. Subsequently, we employed endoscopic- and computed tomography-guided RT and validated rectal tumor growth and response rates to therapy using small-animal magnetic resonance imaging and endoscopic follow-up. Results: Rectal tumor formation was successfully induced in all mice after 2 organoid injections. Clinically relevant RT regimens with 5 × 5 Gy significantly delayed clinical signs of tumor progression and significantly improved survival. Consistent with human disease, rectal tumor progression correlated with the development of liver and lung metastases. Notably, long-term survivors after RT showed no evidence of tumor recurrence, as demonstrated by in vivo radiologic tumor staging and histopathologic examination. Conclusions: Our novel mouse model combines orthotopic tumor growth via noninvasive and precise rectal organoid injection and small-animal RT. This model holds significant promise for investigating the effect of tumor cell-intrinsic aspects, genetic alterations of the host, and exogenous factors (eg, nutrition or microbiota) on RT outcomes. Furthermore, it allows for the exploration of combination therapies involving chemotherapy, immunotherapy, or novel targeted therapies.

Novel radiation and targeted therapy combinations for improving rectal cancer outcomes

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.

Combined radiation strategies for novel and enhanced cancer treatment

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting

Combinatorial Approaches for Chemotherapies and Targeted Therapies with Radiation: United Efforts to Innovate in Patient Care

Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer

Locally Advanced Rectal Cancer: Time for Precision Therapeutics.

Novel Tumor Organoid-Based Mouse Model to Study Image Guided Radiation Therapy of Rectal Cancer After Noninvasive and Precise Endoscopic Implantation

Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review

Key clinical trials in rectal cancer shaping the current treatment paradigms: reference guide for radiologists

An organoid platform reveals MEK-PARP co-targeting to enhance radiation response in rectal cancer

Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review

Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer

Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management

[New Radiation Therapy Concepts in Non-Metastatic Lung Cancer]

Surgical Outcomes after Radiotherapy in Rectal Cancer

Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin

Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy

New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy

Combination Immunotherapy With Radiotherapy in Non‐Small Cell Lung Cancer: A Review of Evidence

[Radiotherapy Standard and Progress in Locally Advanced Rectal Cancer].